Amphastar Pharmaceuticals Inc (AMPH)
38.63
-1.42
(-3.55%)
USD |
NASDAQ |
Apr 18, 16:00
38.01
-0.62
(-1.60%)
Pre-Market: 09:13
Amphastar Pharmaceuticals Total Long Term Debt (Quarterly): 590.02M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 590.02M |
September 30, 2023 | 638.64M |
June 30, 2023 | 501.20M |
March 31, 2023 | 75.04M |
December 31, 2022 | 75.88M |
September 30, 2022 | 75.69M |
June 30, 2022 | 75.93M |
March 31, 2022 | 76.51M |
December 31, 2021 | 76.98M |
September 30, 2021 | 77.81M |
June 30, 2021 | 38.54M |
March 31, 2021 | 44.51M |
December 31, 2020 | 46.45M |
September 30, 2020 | 45.07M |
June 30, 2020 | 46.70M |
March 31, 2020 | 47.87M |
December 31, 2019 | 47.14M |
September 30, 2019 | 45.05M |
June 30, 2019 | 46.73M |
March 31, 2019 | 48.56M |
December 31, 2018 | 50.21M |
September 30, 2018 | 51.20M |
Date | Value |
---|---|
June 30, 2018 | 52.59M |
March 31, 2018 | 45.77M |
December 31, 2017 | 47.16M |
September 30, 2017 | 48.44M |
June 30, 2017 | 46.31M |
March 31, 2017 | 36.41M |
December 31, 2016 | 37.72M |
September 30, 2016 | 42.70M |
June 30, 2016 | 42.65M |
March 31, 2016 | 40.27M |
December 31, 2015 | 41.10M |
September 30, 2015 | 46.12M |
June 30, 2015 | 47.43M |
March 31, 2015 | 48.42M |
December 31, 2014 | 43.70M |
September 30, 2014 | 51.35M |
June 30, 2014 | 53.52M |
March 31, 2014 | 41.50M |
December 31, 2013 | 32.17M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
38.54M
Minimum
Jun 2021
638.64M
Maximum
Sep 2023
140.62M
Average
75.04M
Median
Mar 2023
Total Long Term Debt (Quarterly) Benchmarks
Eli Lilly and Co | 25.23B |
Dentsply Sirona Inc | 2.118B |
Pacira BioSciences Inc | 522.44M |
Organon & Co | 8.76B |
NovaBay Pharmaceuticals Inc | 1.137M |